February 28th, 2011

Reuters reports:

“An experimental gel containing a prescription HIV drug has been shown for the first time to protect rectal tissue against the virus that causes AIDS, according to new research.

The gel, containing Gilead Sciences Inc’s AIDS drug tenofovir, has previously been shown to sharply reduce HIV infections in women when applied inside the vagina.

The latest study, which involved rectal tissue biopsies taken from HIV-negative men and women who used the product daily for one week, provides the first evidence that tenofovir gel could help reduce the risk of HIV from anal sex.”

Read more from Reuters